20/20 Biolabs, Inc.
AIDX- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- SEC CIK
- 0001139685
No open-market purchases or sales by 20/20 Biolabs, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $297.1K in total; no superinvestor holds it.
Holders of 5% or more of AIDX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of 20/20 Biolabs, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Cohen Jonathan M | 13D | 16.80%1.83M shares | New | Mar 10, 20261 filing | Mar 10, 2026 | SEC |
| Streeterville Capital LLC | 13G | 9.90%543.7K shares | New | Feb 25, 20261 filing | Feb 25, 2026 | SEC |
| Full Succeed International Ltd | 13G | 6.30%651.5K shares | New | Mar 10, 20261 filing | Mar 10, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on 20/20 Biolabs, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 20265:18 PM ET | Full Succeed International Ltdand 2 others | 13G | 6.30%651.5K shares | New | Feb 19, 2026 | SEC |
| Mar 10, 20265:14 PM ET | Cohen Jonathan M | 13D | 16.80%1.83M shares | New | Mar 3, 2026 | SEC |
| Feb 25, 20263:10 PM ET | Streeterville Capital LLCand 2 others | 13G | 9.90%543.7K shares | New | Feb 25, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell 20/20 Biolabs, Inc. shares.
No Form 144 notices for 20/20 Biolabs, Inc. are on file.